See
Genome Information for Amycolatopsis mediterranei
Amycolatopsis mediterranei S699.
This strain is of major industrial and pharmaceutical interest as it produces antibiotic rifamycin, derivatives of which are used for curing tuberculosis and leprosy.
| Accession | PRJNA43503 |
| Data Type | Genome sequencing |
| Scope | Monoisolate |
| Organism | Amycolatopsis mediterranei S699[Taxonomy ID: 713604] Bacteria; Bacillati; Actinomycetota; Actinomycetes; Pseudonocardiales; Pseudonocardiaceae; Amycolatopsis; Amycolatopsis mediterranei; Amycolatopsis mediterranei S699 |
| Publications | Verma M et al., "Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699.", J Bacteriol, 2011 Oct;193(19):5562-3 |
| Submission | Registration date: 19-Jul-2011
University of Delhi |
| Locus Tag Prefix | RAM |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| Nucleotide (Genomic DNA) | 1 |
| Protein Sequences | 9575 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 1 |
| Assembly | 1 |